E.M.S.F. Ribeiro
Impact in
-
- Carcinogens and Genotoxicity Assessment
- Cancer-related molecular mechanisms research
-
- Chemokine receptors and signaling
Papers in
-
- Genomics and Chromatin Dynamics 2
- Epigenetics and DNA Methylation 2
- S100 Proteins and Annexins 2
-
- Cancer Genomics and Diagnostics 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Iglenir João Cavalli (9 shared papers)Karin Braun-Prado (2 shared papers)Rubens Silveira de Lima (6 shared papers)Anamaria A. Camargo (1 shared paper)Fabrício F. Costa (2 shared papers)Giseli Klassen (2 shared papers)Luciane R. Cavalli (3 shared papers)I.M.S. Cólus (1 shared paper)
- Journals
- Journal of Clinical Pathology (1 paper)Biomolecules (1 paper)Molecular Cytogenetics (1 paper)Leukemia Research (1 paper)Brazilian Journal of Medical and Biological Research (1 paper)
- Partner nations
- BrazilUnited StatesUnited Kingdom
In The Last Decade
E.M.S.F. Ribeiro
12 papers receiving 141 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 39
- Oncology 44
- Molecular Biology 90
- Immunology 25
- Genetics 11
Countries citing papers authored by E.M.S.F. Ribeiro
This map shows the geographic impact of E.M.S.F. Ribeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M.S.F. Ribeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M.S.F. Ribeiro more than expected).
Fields of papers citing papers by E.M.S.F. Ribeiro
This network shows the impact of papers produced by E.M.S.F. Ribeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M.S.F. Ribeiro. The network helps show where E.M.S.F. Ribeiro may publish in the future.
Co-authors
The 25 scholars most cited alongside E.M.S.F. Ribeiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 53 | |
| 2 | 2006 | 26 | |
| 3 | 2016 | 15 | |
| 4 | 2015 | 15 | |
| 5 | 2004 | 12 | |
| 6 | 2016 | 7 | |
| 7 | 2007 | 6 | |
| 8 | 1999 | 5 | |
| 9 | 2022 | 3 | |
| 10 | 2019 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2002 | 1 |
About E.M.S.F. Ribeiro
E.M.S.F. Ribeiro is a scholar working on Molecular Biology, Cancer Research, Genetics, Pathology and Forensic Medicine and Oncology, having authored 12 papers that have together received 145 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Genomics and Chromatin Dynamics (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers), BRCA gene mutations in cancer (2 papers), S100 Proteins and Annexins (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Cancer Research (39 citations), Oncology (44 citations), Molecular Biology (90 citations), Immunology (25 citations) and Genetics (11 citations). E.M.S.F. Ribeiro has collaborated with scholars based in Brazil, United States and United Kingdom. Frequent co-authors include Iglenir João Cavalli, Karin Braun-Prado, Rubens Silveira de Lima, Anamaria A. Camargo, Fabrício F. Costa, Giseli Klassen, Luciane R. Cavalli, I.M.S. Cólus, Bassem R. Haddad and Guy Costa. Their work appears in journals such as Journal of Clinical Pathology, Biomolecules, Molecular Cytogenetics, Leukemia Research and Brazilian Journal of Medical and Biological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.